US-based digital health company Telcare has received $32.5m in a series C round that featured Qualcomm Ventures, the corporate venturing division of communications technology manufacturer Qualcomm.
The round was led by Wells Fargo-backed venture capital firm Norwest Venture Partners, and also included Mosaic Health Solutions and VC firm Sequoia Capital.
Telcare has developed a mobile app that monitors blood glucose levels to spot diabetes. The funding will be used to increase its work in diabetes and to expand the platform to related conditions.
Andrew Flanagan, chief executive of Telcare, said: “This investment enables us to deliver on our vision by scaling our reach and capabilities.”
Qualcomm had previously invested in a $25.5m series B round raised by Telcare in 2012 alongside Sequoia Capital. Telcare previously secured $4.5m in a 2011 series A round that also featured Qualcomm.